Experience

Numab Therapeutics AG

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• Laboratory Manager and Biosafety Officer

  • Oct 2022 - Present

• Research Associate II

  • Aug 2020 - Sep 2022



Molecular Partners

• Switzerland
• Biotechnology Research
• 100 - 200 Employee

• Senior Research Associate

  • Jan 2013 - Jul 2020

  Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. I conduct studies to understand the mechanism of action of specific DARPins through project based work. Assessment of DARPins via techniques such as: ELISA, western blotting, flow cytometry, small-scale protein expression and purification, cell-based assays.



Baker Heart and Diabetes Institute

• Australia
• Biotechnology Research
• 200 - 300 Employee

• Research Assistant

  • Jan 2005 - Sep 2012

  Our lab used a combination of cell biology, nano- and molecular biology techniques to better understand the pathophysiology of thrombosis, atherosclerosis and inflammation. My expertise in experimental procedures included mainly flow cytometry, protein biochemistry, cell culture, microscopy, aggregometry, phage display, protein purification and molecular biology. I was also responsible for laboratory organization and management, and induction/training of students and new employees. I have been a member of the OH&S committee and purchase and equipment committee.



Department of Cardiology, University Hospital Freiburg

• Medical Practices
• 1 - 100 Employee

• Research Assistant

  • Aug 1999 - Dec 2004

  Our lab used a combination of cell biology and molecular biology techniques to better understand the pathophysiology of thrombosis, atherosclerosis and inflammation. My expertise in experimental procedures included mainly flow cytometry, protein biochemistry, cell culture, microscopy, aggregometry, phage display, protein purification and molecular biology. I was also responsible for laboratory organization and management, and induction/training of students and new employees. Our lab used a combination of cell biology and molecular biology techniques to better understand the pathophysiology of thrombosis, atherosclerosis and inflammation. My expertise in experimental procedures included mainly flow cytometry, protein biochemistry, cell culture, microscopy, aggregometry, phage display, protein purification and molecular biology. I was also responsible for laboratory organization and management, and induction/training of students and new employees.



University Hospital Freiburg, Clinical Chemistry

• MTA

  • Apr 1999 - Jul 1999

  Field of activity: Clinical chemistry, Hematology, Coagulation Field of activity: Clinical chemistry, Hematology, Coagulation



Department of Clinical Immunology and Rheumatology, University Hospital, Freiburg

• Medical Technical Assisstant

  • Apr 1998 - Mar 1999

  Field of activity: Immunofluorescence (ANA/AMA), ENA, Flow cytometry Field of activity: Immunofluorescence (ANA/AMA), ENA, Flow cytometry



Pathology Laboratory, St. Josefs-Hospital Offenburg, Germany

• Medical Technical Assisstant

  • May 1993 - Mar 1998

  Field of activity: Clinical chemistry, Hematology, Coagulation, Immunohematology, Immunology Field of activity: Clinical chemistry, Hematology, Coagulation, Immunohematology, Immunology